Joint Pain Injections Market
Joint Pain Injections Market Forecasts to 2030 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Joint Pain Injections Market is accounted for $5.2 billion in 2023 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 10.6% during the forecast period. Direct injections into the joints are used to treat joint pain in order to reduce swelling and inflammation. In the elderly population, joint discomfort is typically brought on by pre-existing conditions. The widespread ailment known as arthritis mostly affects the hip, knee, elbow, shoulder, and facet joints of the spine. It causes inflammation in the joints and makes them uncomfortable.
According to the Arthritis Research UK report, “The State of Musculoskeletal Health 2018”, it is estimated that 17.8 million people suffer with a musculoskeletal condition in the UK which is around 28.9% of the total population of the country.
Market Dynamics:
Driver:
Increased occurrence of arthritis
The most frequent cause of adult disability worldwide is arthritis. Corticosteroids and hyaluronic acid injections, for example, can significantly reduce pain by lubricating the joints and decreasing inflammation, which relieves stiffness and discomfort. By carefully administering medicine to the region of pain or inflammation, injections target the afflicted joint, increasing efficacy and minimizing systemic adverse effects. The market is expanding as a result of these causes.
Restraint:
Side effects and allergies
Joint pain injection side effects and allergies that patients experienced have turned out to be a significant barrier to the market's expansion. Some patients who had joint pain injections had damage to their cartilage and nerves, which has had an impact on the manufacturing and marketing of these medical devices. Furthermore, the largest obstacle to the industry's expansion has been shown to be skin discoloration and infections that result from patients using joint pain inoculations.
Opportunity:
Growing prevalence of joint-related disorders
One driver of the market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.
Threat:
Lack of knowledge
The average population has never heard about joint pain injections. Platelet-rich plasma, corticosteroids, and hyaluronic acid injections are used to relieve joint discomfort. To utilize these injections, one must possess a great deal of expertise and training. Physicians and other medical professionals frequently inject people for joint discomfort. The tools and training needed for professionals to do this are supplied. The lack of government measures to encourage joint pain injections, however, limits the market's growth.
Covid-19 Impact:
The COVID-19 pandemic has turned out to be an unparalleled worldwide public health disaster that has impacted practically every business, and its repercussions are anticipated to have an impact on every industry's growth over the projection period. Globally, there have been several shifts in supply chain rerouting, purchasing patterns, customer demand and behavior, and major government efforts. The epidemic has altered people's lifestyles, drug usage patterns, and other health-related habits.
The hyaluronic acid injections segment is expected to be the largest during the forecast period
The hyaluronic acid injections segment is expected to be the largest during the forecast period. Patients who have already tried ineffective treatments like acetaminophen and other opioids are treated with hyaluronic acid injections for knee discomfort associated with osteoarthritis. Injections of hyaluronic acid have grown in favor as a non-surgical treatment option, especially considering that physicians are generally reluctant to administer intraarticular corticosteroid injections on a regular basis.
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies frequently employ medical professionals with specific training in injectable administration in addition to competent pharmacists, assuring correct technique and lowering the chance of problems. Patients have access to a wider range of pain management options, including different types of injections or combination therapies tailored to their specific needs.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to the high prevalence of musculoskeletal disorders, growing geriatric population. This is ascribed to a number of factors, including the large concentration of market participants in the area, the robust presence of industry companies in the area, improved healthcare infrastructure, and public and industry stakeholder knowledge of available technology. The market in this area is expanding due in part to a high rate of adoption of cutting-edge technology.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period. The rising incidence of osteoarthritis and the entry of viscosupplement products by regional competitors are propelling the growth of the respective markets in each country. Furthermore, ideal circumstances for the patient population's acceptance of these therapies are created by the growing knowledge of cutting-edge joint pain treatments in the area.
Key players in the market
Some of the key players in Joint Pain Injections market include Anika Therapeutics, Inc., Sanofi aventis LLC, Ferring B.V., Zimmer Biomet, Bioventus LLC, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, Ferring B.V., Pacira Biosciences, OrthogenRx, Pfizer, Lifecore Biomedical, Wright Medical Group, AbbVie and Stryker.
Key Developments:
In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.
In March 2022, Sanofi collaborated with IGM Biosciences Inc. to develop, manufacture, and introduce potential therapeutics in the fields of immunology and inflammation.
Joint Types Covered:
• Shoulder and Elbow
• Facet Joints of the Spine
• Knee and Ankle
• Hip Joint
• Other Joint Types
Injection Types Covered:
• Interleukin Inhibitors
• Hyaluronic Acid Injections
• Steroid Joint Injections
• Platelet-rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Injection Types
Distribution Channels Covered:
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
End Users Covered:
• Hospitals
• Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introducton
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Joint Pain Injections Market, By Joint Type
5.1 Introduction
5.2 Shoulder and Elbow
5.3 Facet Joints of the Spine
5.4 Knee and Ankle
5.5 Hip Joint
5.6 Other Joint Types
6 Global Joint Pain Injections Market, By Injection Type
6.1 Introduction
6.2 Interleukin Inhibitors
6.3 Hyaluronic Acid Injections
6.4 Steroid Joint Injections
6.5 Platelet-rich Plasma (PRP) Injections
6.6 Placental Tissue Matrix (PTM) Injections
6.7 Other Injection Types
7 Global Joint Pain Injections Market, By Distribution Channel
7.1 Introduction
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
8 Global Joint Pain Injections Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Other End Users
9 Global Joint Pain Injections Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Anika Therapeutics, Inc.
11.2 Sanofi aventis LLC
11.3 Ferring B.V.
11.4 Zimmer Biomet
11.5 Bioventus LLC
11.6 Allergen Plc.
11.7 Pfizer Inc.
11.8 Chugai Pharmaceutical Co. Ltd
11.9 SEIKAGAKU Corporation
11.10 Ferring B.V.
11.11 Pacira Biosciences
11.12 OrthogenRx
11.13 Pfizer
11.14 Lifecore Biomedical
11.15 Wright Medical Group
11.16 AbbVie
11.17 Stryker
List of Tables
1 Global Joint Pain Injections Market Outlook, By Region (2021-2030) ($MN)
2 Global Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
3 Global Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
4 Global Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
5 Global Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
6 Global Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
7 Global Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
8 Global Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
9 Global Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
10 Global Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
11 Global Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
12 Global Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
13 Global Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
14 Global Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
15 Global Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
16 Global Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
17 Global Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
18 Global Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
19 Global Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
20 Global Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
21 Global Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
22 Global Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
23 North America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
24 North America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
25 North America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
26 North America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
27 North America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
28 North America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
29 North America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
30 North America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
31 North America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
32 North America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
33 North America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
34 North America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
35 North America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
36 North America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
37 North America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
38 North America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
39 North America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
40 North America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
41 North America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
42 North America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
43 North America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
44 North America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
45 Europe Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
46 Europe Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
47 Europe Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
48 Europe Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
49 Europe Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
50 Europe Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
51 Europe Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
52 Europe Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
53 Europe Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
54 Europe Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
55 Europe Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
56 Europe Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
57 Europe Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
58 Europe Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
59 Europe Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
60 Europe Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
61 Europe Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
62 Europe Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
63 Europe Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
64 Europe Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
65 Europe Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
66 Europe Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
67 Asia Pacific Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
69 Asia Pacific Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
70 Asia Pacific Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
71 Asia Pacific Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
72 Asia Pacific Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
73 Asia Pacific Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
74 Asia Pacific Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
75 Asia Pacific Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
76 Asia Pacific Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
77 Asia Pacific Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
78 Asia Pacific Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
79 Asia Pacific Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
80 Asia Pacific Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
81 Asia Pacific Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
82 Asia Pacific Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
83 Asia Pacific Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
84 Asia Pacific Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
85 Asia Pacific Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
86 Asia Pacific Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
87 Asia Pacific Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
88 Asia Pacific Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
89 South America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
90 South America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
91 South America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
92 South America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
93 South America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
94 South America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
95 South America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
96 South America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
97 South America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
98 South America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
99 South America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
100 South America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
101 South America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
102 South America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
103 South America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
104 South America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
105 South America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
106 South America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
107 South America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
108 South America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
109 South America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
110 South America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
111 Middle East & Africa Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
113 Middle East & Africa Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
114 Middle East & Africa Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
115 Middle East & Africa Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
116 Middle East & Africa Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
117 Middle East & Africa Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
118 Middle East & Africa Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
119 Middle East & Africa Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
120 Middle East & Africa Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
121 Middle East & Africa Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
122 Middle East & Africa Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
123 Middle East & Africa Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
124 Middle East & Africa Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
125 Middle East & Africa Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
126 Middle East & Africa Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
127 Middle East & Africa Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
128 Middle East & Africa Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
129 Middle East & Africa Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
130 Middle East & Africa Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
131 Middle East & Africa Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
132 Middle East & Africa Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
